Article
Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase.
Antimicrobial agents and chemotherapy - 1 Dec 2015
Boyer Paul L, Das Kalyan, Arnold Eddy, Hughes Stephen H
Abstract excerpt
Although anti-human immunodeficiency virus type 1 (HIV-1) therapies have become more sophisticated and more effective, drug resistance continues to be a major problem. Zidovudine (azidothymidine; AZT) was the first nucleoside reverse transcriptase (RT) inhibitor (NRTI) approved for the treatment of HIV-1 infections and is still being used, particularly in the developing world. This drug targets the conversion of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
